Hikma Pharmaceuticals Plc Stock Widgets and Gadgets
| HKMPF Stock | USD 22.33 1.92 7.92% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- HKMPF Hikma Pharmaceuticals PLC
- HKMPF 22.33 -1.92
- Low 22.33
- High 22.33
- Alpha -0.12
- Beta -0.16
- Return On Equity 0.15
- Return On Asset 0.077
- Profit Margin 0.14 %
- Operating Margin 0.22 %
- Current Valuation 5.26 B
- Shares Outstanding 220.26 M
- Shares Owned By Insiders 29.67 %
- Shares Owned By Institutions 41.69 %
- Price To Earning 7.89 X
- Price To Book 1.84 X
- Price To Sales 1.63 X
- Revenue 2.55 B
- Gross Profit 1.3 B
- EBITDA 758 M
- Net Income 421 M
- Cash And Equivalents 393 M
- Cash Per Share 1.78 X
- Total Debt 651 M
- Debt To Equity 0.71 %
- Current Ratio 2.12 X
- Book Value Per Share 9.89 X
- Cash Flow From Operations 638 M
- Earnings Per Share 1.50 X
- Price To Earnings To Growth 2.35 X
- Number Of Employees 8.7 K
- Beta 0.35
- Market Capitalization 4.6 B
- Total Asset 4.37 B
- Retained Earnings 1.16 B
- Working Capital 768 M
- Current Asset 1.36 B
- Current Liabilities 592 M
- Z Score 4.2
- Annual Yield 0.02 %
- Five Year Return 1.80 %
- Net Asset 4.37 B
- Last Dividend Paid 0.55
- Daily Balance Of Power (9,223,372,036,855)
- Rate Of Daily Change 0.92
- Day Median Price 22.33
- Day Typical Price 22.33
- Price Action Indicator (0.96)
- Period Momentum Indicator (1.92)
Market Snapshot Widget Example
DAX Index Germany | 18,089 0.27 | |
Taiwan Weighted Taiwan | 20,132 2.72 | |
PSI 20 Stock Portugal | 6,530 0.95 | |
CROBEX Croatia | 2,786 0.05 | |
Budapest SE Hungary | 66,377 0.66 | |
IDX 30 Jakarta Indonesia | 472.42 0.44 | |
ISEQ 20 Price Ireland | 1,668 0.96 | |
NYSE Comp USA | 17,758 0.19 | |
Tel Aviv 35 Israel | 1,938 1.13 | |
Coreshares Index Tracker South Afric | 1,056 1.44 | |
IPC MEXICO Mexico | 56,464 0.3 | |
KL Technology Malaysia | 64.16 1.55 | |
IBEX 35 Index Spain | 11,028 0.43 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,580 0.02 | |
SPASX Dividend Opportunities Australia | 1,657 0.08 | |
HNX 30 Vietnam | 471.55 2.01 | |
Bucharest BET-NG Romania | 1,203 0.1 | |
AMS Small Cap Netherlands | 1,204 1.30 | |
Oslo Exchange Mutual Norway | 1,304 1.04 | |
BEL Small Belgium | 9,023 0.03 | |
RTSI Index Russia | 1,172 0.66 | |
Basic Materials Brazil | 5,814 0.49 | |
Swiss Leader Price Switzerland | 1,857 0.69 | |
Fondo Mutuo ETF Chile | 1,416 0.34 | |
Athens General Comp Greece | 1,449 0.06 | |
Stock Exchange Of Thailand | 1,361 0.27 | |
PX Prague Stock Czech Repub | 1,565 0.49 | |
THE PHILIPPINE STOCK Philippines | 6,573 1.01 | |
WIG 30 Poland | 3,051 0.89 | |
BIST Electricity Turkey | 592.91 0.41 |
Investing Ideas
In addition to having Hikma Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Hikma Pharmaceuticals
Compare Hikma Pharmaceuticals To Peers
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hikma Pharmaceuticals PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Hikma Pink Sheet analysis
When running Hikma Pharmaceuticals' price analysis, check to measure Hikma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hikma Pharmaceuticals is operating at the current time. Most of Hikma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hikma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hikma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hikma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |